News and Conferences
1
-
Published!
Read morePublished! We're feeling proud of Sandor Kantor and his colleagues at Transpharmation as one of their recent studies about the sleep and EEG effects of ketamine in a rat model of treatment-resistant depression has been accepted for publication in Behavioural Brain Research, published by Elsevier. -
The Neuro4D Conference
Read moreThe Neuro4D Conference 15-16 May in Mainz, Germany is an international conference that unites drug discovery companies, service and technology providers and academic innovators who specialise in proteopathic neurodegenerative diseases. Transpharmation is pleased to be one of the event’s key sponsors.
-
Psychedelic Therapeutics and Drug Development Conference
Read morePsychedelic Therapeutics and Drug Development Conference taking place 15-16 May in San Francisco is designed to bring together world leading researchers and leaders in academia, industry, the nonprofit sector and government to discuss the challenges and opportunities facing those engaged in R&D of psychedelics for health conditions with considerable unmet need.
-
New poster added to our publications page, recently presented at ADPD!
Read morenull -
New poster added to our publications page, recently presented at FENS
Read morenull -
FENS Regional Meeting 2023
Read moreFederation of European Neuroscience Societies (FENS) taking place 3 - 5 May in Algarve, Portugal will be covering all domains of modern neuroscience.
-
Neuroimmunology Drug Development Summit
Read moreNeuroimmunology Drug Development Summit taking place April 25 - 27 in Boston, Massachusetts is focusing this year on glial biology, neuroinflammatory biomarkers, and optimizing various approaches to target the likes of LRKK2, TREM2, and more.
-
New clients, different time zones
Read moreNew clients, different time zones Transpharmation’s scientists have been busy traversing time zones to hold meetings with clients old and new during the first quarter of 2023. -
AD/PD 2023
Read moreAD/PD March 28th - April 1st 2023, Gothenburg, Sweden AD/PD is the world renowned international conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
-
OARSI World Congress
Read more17th - 20th March; Denver, USA Scientists and health care professionals focused on the prevention and treatment of osteoarthritis meet at the OARSI World Congress. Transpharmation looks forward to the promotion and presentation of research, education and gaining new knowledge insights.
1
Want to see our latest study results?
Sign up for our newsletter.
Newsletters
- Accelerate your Drug Discovery Research. Proven results, fast and cost effective
2023-06-07
- Urgent Treatments Needed for Parkinson's Disease
2023-05-16
- Poor bioavailability, is the liver or intestine to blame?
2023-05-03
- Laser Doppler; new validated protocols revealed.
2023-04-21
- Epilepsy models leading the way. Read on for results.
2023-03-27
- Profiling anti-inflammatory drugs; from rodent to human
2023-03-02
- The Mismatch Negativity Challenge
2023-01-25
- Accelerate your drug discovery research. Proven science based results cost-effectively.
2022-12-20
- Anxiety. Three preclinical tests; data revealed...
2022-12-12
- Seven new posters, presented at SfN, now available to view.
2022-11-23
- Name change announcement! News from the CEO.
2022-11-04
- Chronic fatigue: different etiologies influence translational models
2022-10-18
- Seven new translational studies to share with you at this year's SfN event. Read on for poster titles and contact details.
2022-10-03
- Translational value increased with non-evoked pain measures.
2022-09-21
- Rapid access to PK non-rodent studies. Leading expertise.
2022-09-01
- Essential tremor research
2022-08-19
- Can a psychedelic experience be modelled in rats?
2022-08-01
- Gender Differences in Pain. New research revealed!
2022-06-30
- New data on the effect of single dose psilocybin!
2022-05-25
- From ketamine to psychedelics, join our webinar starting tomorrow!
2022-05-09
- Long term delayed effects of psychedelics in preclinical models. Trailblazing results revealed!
2022-04-05
- Accreditation awarded with flying colours
2022-03-01
- Breaking news! Merger announcement between Transpharmation and InterVivo Solutions.
2022-02-08
- Take a look! New posters, nine therapeutic areas available to view now.
2021-12-01
- Nine new compelling studies to be revealed at SfN21!
2021-11-03
- Can changes in EEG improve neuropathic pain treatments?
2021-10-11
- 40Hz ASSR: sounds that change our thoughts about schizophrenia
2021-08-31
- Clerkenwell Health and Transpharmation combine lab and human trials for psilocybin
2021-08-09
- Translational endpoints for preclinical pain - improving your chances.
2021-07-01
- Transpharmation aims for global standard. Let's talk about lab sustainability.
2021-06-02
- Targeting the unmet medical need in Parkinson's Disease - the fastest growing neurological disorder.
2021-04-15
- Psilocybin: the power of mental reorganisation
2020-12-06
- Expansion to world class premises
2020-11-04
- Multiple therapeutic indications
2020-10-05
- Focus on pain
2020-09-04
- Gene therapies for body and brain in Duchenne Muscular Dystrophy, progress moves forward.
2020-03-08
- Announcing Transpharmation Poland!
2020-02-08